La CSLZ atténue l'inflammation associée à la colite en inhibant les voies PI3K/Akt et MAPK, soulignant son potentiel en tant que nouvel agent thérapeutique pour la colite ulcéreuse.
Building similarity graph...
Analyzing shared references across papers
Loading...
Guangtao Zhang
Binzhou Medical University
Zhengxian Gao
Shenzhen University
Tianjie Xie
Combinatorial Chemistry & High Throughput Screening
Shenzhen University
Shenzhen University Health Science Center
Peking University Shenzhen Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Zhang et al. (Mon,) ont étudié cette question.
synapsesocial.com/papers/69d893406c1944d70ce04429 — DOI: https://doi.org/10.2174/0113862073403084251212071505
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: